Latest Paul O'Connor Stories

2011-10-06 10:58:34

The drug also increased the length of time before a patient relapsed and more patients taking it remained free of relapses A new oral drug has been shown in a large international clinical trial to significantly reduce the relapse rate of people with multiple sclerosis and to slow the progression of the disease. The results of the Phase 3 trial of the drug teriflunomide were published in The New England Journal of Medicine on Thursday. "This could be a safe, effective and convenient...

Word of the Day
  • Color; hue; complexion.
This word is Middle English in origin.